It seems that much of our identity is wrapped up in the notion of what we do for a living.  When making casual conversation with people we’ve just met, the question of occupation often arises.  More often than not, the real answer to that question is far too complex for these conversations so we try to capture the essence of our livelihood in a one line bullet point: I’m a physician; I’m a banker; I’m a drug rep etc.  In sales, they call it the “elevator pitch” – the succinct answer you would give someone on a 20 second ride in an elevator.

The need to be succinct doesn’t change even when talking to those in our line of business.  Though Northwind Pharmaceuticals provides many products, our core competency is helping our clinics dispense medications to their patients.  The answer often changes based on your audience: Northwind provides pharmaceutical dispensing services or Northwind offers dispensing software or Northwind distributes injectable drugs. The problem with the one-liner is that it doesn’t make any value judgments – it doesn’t really say whether or not you do these things well.

When thinking of your clinic, the same rules apply.  Every conversation brands your operation.   Sure, you might specialize in internal medicine but what is it you are offering your patients?  You might be able to explain your specialty in 50 words or less but what does your receptionist say when asked?  At the highest level, you could say that “we make people well” but that doesn’t quite capture it, does it?  Does all of your staff really understand all that you do for patients?  These questions are purely rhetorical.  The goal is to look at the value you provide a little differently.  The “elevator pitch” should answer what you do but it should also give a hint as to how you do it better.  If you’re curious about how your staff describes your practice in the outside world, try asking them “what do we do?” and see how they answer.  You might be surprised.

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading